Skip to main content
SpringerLink
Log in

Optimization of an Alum-Adsorbed Vaccine Powder Formulation for Epidermal Powder Immunization

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To develop stable and effective aluminum salt (alum)-adsorbed vaccine powder formulations for epidermal powder immunization (EPI) via a spray freeze-drying (SFD) process.

Methods. Powder properties were determined using particle size analysis, tap density, and scanning electron microscopy. Alum coagulation was monitored via optical microscopy and particle sedimentation. Protein analysis was determined by the BCA protein assay, SDS-PAGE, and an enzyme immunoassay. In vivo immunogenicity and skin reactogenicity were performed on hairless guinea pigs and pigs, respectively.

Results. SFD of hepatitis B surface antigen (HBsAg) adsorbed to aluminum hydroxide or aluminum phosphate using an excipient combination of trehalose/mannitol/dextran produced vaccine powders of dense particles and satisfactory powder flowability and hygroscopicity. This formulation also offered excellent long-term stability to the powder and the antigen. The two most important factors influencing alum particle coagulation are the freezing rate and the concentration of aluminum in the liquid formulation for SFD. The SFD vaccines, when delivered to hairless guinea pigs by EPI or injected intramuscularly after reconstitution, were as immunogenic as the original liquid vaccine. A further study showed that EPI with SFD alum-adsorbed diphtheria-tetanus toxoid vaccine was well tolerated, whereas needle injection of the liquid formulation caused persistent granuloma.

Conclusions. Stabilization of alum-adsorbed vaccine by SFD has important implications in extending vaccination to areas lacking a cold chain for transportation and storage and may also accelerate the development of new immunization technologies such as EPI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. T. Glenny, C. G. Pope, H. Waddington, and U. Wallace. Antigenic value of toxoid precipitated by potassium alum. J. Pathol. Bacteriol. 29:38–45 (1926).-

    Google Scholar 

  2. R. K. Gupta. Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 32:155–172 (1998).-

    Google Scholar 

  3. R. G. White. Concepts relating to the mode of action of adjuvants. Symp. Ser. Immunobiol. Stand. 6:3–12 (1967).-

    Google Scholar 

  4. D. Chen. Y-F, Maa, and J. Haynes. Needle-free epidermal powder immunizations. Expert Vaccine Rev. 1:265–276 (2002).-

    Google Scholar 

  5. A. F. Charest, J. McDougall, and M. B. Goldstein. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am. J. Kidney Dis. 36:976–982 (2000).-

    Google Scholar 

  6. A. Egemen, S. Aksit, Z. Kurugol, S. Erensoy, A. Bilgic, and M. Akilli. Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children. Vaccine 16:1511–1515 (1998).-

    Google Scholar 

  7. A. Sabchareon, P. Chantavanich, S. Pasuralertsakul, C. Pojjaroen-Anant, V. Prarinyanupharb, P. Attanath, V. Singhasivanon, W. Buppodom, and J. Lang. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr. Infect. Dis. J. 17:1001–1007 (1998).-

    Google Scholar 

  8. M. Vogelbruch, B. Nuss, M. Korner, A. Kapp, P. Kiehl, and W. Bohm. Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy 55:883–887 (2000).-

    Google Scholar 

  9. A. C. Pembroke and R. H. Marten. Unusual cutaneous reactions following diphtheria and tetanus immunization. Clin. Exp. Dermatol. 4:345–348 (1979).-

    Google Scholar 

  10. D. Chen, R. L. Endres, C. A. Erickson, K. F. Weis, M. W. McGregor, Y. Kawaoka, and L. G. Payne. Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice. Nature Med. 6:1187–1190 (2000).-

    Google Scholar 

  11. D. Chen, C. A. Erickson, R. L. Endres, S. B. Periwal, Q. Chu, C. Shu, Y.-F. Maa, and L. G. Payne. Adjuvantation of epidermal powder immunization. Vaccine 19:2908–2917 (2001).-

    Google Scholar 

  12. D. Chen, K. Weis, A. Bucklen, C. A. Erickson, R. L. Endres, C. Lively, and L. G. Payne. Epidermal powder immunization induces both cytotoxic T lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses. J. Virol. 75:11630–11640 (2001).-

    Google Scholar 

  13. D. Chen, C. Y. Zuleger, Q. Chu, Y.-F. Maa, J. Osorio, and L. G. Payne. Epidermal powder immunization with recombinant HIV gp120 induces both humoral and cellular immune responses in mice. AIDS Res. Hum. Retroviruses 18:715–722 (2002).-

    Google Scholar 

  14. M. I. Zapata, J. R. Feldkamp, G. E. Peck, J. L. White, and S. L. Hem. Mechanism of freeze–thaw instability of aluminum hydroxycarbonate and magnesium hydroxide gels. J. Pharm. Sci. 73:3–8 (1984).-

    Google Scholar 

  15. Y.-F. Maa, L. Zhao, L. G. Payne, and D. Chen. Stabilization of alum-adjuvanted vaccine powder formulation: Mechanism and application. J. Pharm. Sci. 92:319–332 (2003).-

    Google Scholar 

  16. D. Diminsky, N. Moav, M. Gorecki, and Y. Barenhol. Physical, chemical, and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 18:3–17 (1999).-

    Google Scholar 

  17. M. Kyosuke, I. Yoshimitsu, K. Tetsuo, and O. Nobuya. Hepatitis B vaccine and method for its preparation. European Patent #0130619 (1989).-

  18. Z. Csizer, K. Sikos, L. Bacskai, E. Niedermayer, L. Rethy, and J. Zsidai. Process for the preparation of lyophilized, adsorbed polyvalent vaccines. United States Patent #4,578,270 (1986).-

  19. H. Costantino, L. Firouzabadian, K. Hogeland, C. Wu, C. Beganski, K. Carrisquilla, M. Cardova, K. Griebenow, S. Zale, and M. Tracy. Protein spray freeze drying. Effect of atomization conditions on particle size and stability. Pharm. Res. 17:1374–1381 (2000).-

    Google Scholar 

  20. Y.-F. Maa, P.-A. Nguyen, T. Sweeney, S. J. Shire, and C. C. Hsu. Protein inhalation powder: Spray drying vs. spray freeze drying. Pharm. Res. 16:249–254 (1999).-

    Google Scholar 

  21. Y.-F. Maa and P.-A. Nguyen. Method of spray freeze drying proteins for pharmaceutical administration. United States Patent #6,282,282 (2001).-

  22. Y.-F. Maa and S. Prestrelski. Biopharmaceutical powders: Particle formation and formulation considerations. Curr. Pharm. Biotechnol. 1:283–302 (2000).-

    Google Scholar 

  23. C. Sonner, Y.-F. Maa, and G. Lee. Spray-freeze-drying for protein powder preparation: Particle characterization and a case study with trypsinogen stability. J. Pharm. Sci. 91:2122–2139 (2002).-

    Google Scholar 

  24. S. D. Allison, M. C. Manning, T. W. Randolph, K. Middleton, A. Davis, and J. F. Carpenter. Optimization of storage conditions of lyophilized actin using combination of disaccharides and dextran. J. Pharm. Sci. 89:199–214 (2000).-

    Google Scholar 

  25. S. J. Prestrelski, N. Tedeschi, T. Arakawa, and J. F. Carpenter. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys. J. 65:661–671 (1993).-

    Google Scholar 

  26. H. R. Costantino, J. D. Andya, P.-A. Nguyen, N. Dasovich, T. D. Sweeney, S. J. Shire, C. C. Chung, and Y.-F. Maa. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J. Pharm Sci. 87:1406–1411.-

  27. H. Sueki, C. Gammal, K. Kudoh, and A. M. Kligman. Hairless guinea pig skin: anatomical basis for studies of cutaneous biology. Eur. J. Dermatol. 10:357–364 (2000).-

    Google Scholar 

  28. H. Miyauchi and T. Horio. A new animal model for contact dermatitis: the hairless guinea pig. J. Dermatol. 19:140–145 (1992).-

    Google Scholar 

  29. N. A. Monteiro-Riviere, D. G. Bristol, T. O. Manning, R. A. Rogers, and J. E. Riviere. Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. J. Invest. Dermatol. 95:582–586 (1990).--

    Google Scholar 

Download references

Author information

Author notes

  1. Yuh-Fun Maa, Cassandra Shu & Mahmoud Ameri

    Present address: PowderJect Vaccines, Inc., Alza Corporation, Madison, Wisconsin, 53711, Mountain View, California, 94043

Authors and Affiliations

  1. PowderJect Vaccines, Inc., Alza Corporation, Madison, Wisconsin, 53711, Mountain View, California, 94043

    Cindy Zuleger, Jenny Che, Jorge E. Osorio, Lendon G. Payne & Dexiang Chen

Authors
  1. Yuh-Fun Maa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cassandra Shu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahmoud Ameri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cindy Zuleger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jenny Che
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jorge E. Osorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lendon G. Payne
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dexiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuh-Fun Maa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maa, YF., Shu, C., Ameri, M. et al. Optimization of an Alum-Adsorbed Vaccine Powder Formulation for Epidermal Powder Immunization. Pharm Res 20, 969–977 (2003). https://doi.org/10.1023/A:1024493719236

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024493719236

Search

Navigation